ASM Global’s SAVOR Food Division Announces U.S. Winners of World’s Premier Search Competition for Young Culinary and Hospitality Talent
24.8.2023 16:00:00 EEST | Business Wire | Press release
SAVOR, the culinary division of the world’s leading producer of live-event experiences, ASM Global, has announced Marcus Youn, chef from Knife Pleat, Regina Gutierrez, waiter from The French Laundry and Mitchell Coriell, mixologist from Soho House – Malibu the winners of the American round of the renowned World Young Chef Young Waiter (WYCYW) competition.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230823913776/en/
Judge/Chef Roland Passot (right) evaluates contestant Marcus Youn during the chef competition of Young Chef Young Waiter USA on Aug. 21, 2023, at the CIA at Copia. Youn would go on to win first place in the competition and heads to Monaco to compete in the world finals in November. (Photo: Andreas Zhou/SAVOR)
Now in its 44th year, WYCYW is the premier competition promoting hospitality as a career choice, aimed at finding the world’s most skilled chefs, waiters and waitresses under the age of 28.
All three winners from YCYW USA will go on to compete in the World Young Chef Young Waiter finals on Nov. 23 and 24 at the Lycée Rainier III in Monaco to showcase their abilities to world-class chefs, hospitality experts and mixologists. A total of 21 contestants from nine countries will face off for the chance to win the world title of best chef, waiter and mixologist under the age of 28 as well as a cash prize of $10,000.
The finals of YCYW USA took place on Aug. 21, 2023, at the prestigious The Culinary Institute of America at Copia (CIA) in Napa, California. Each of the 11 talented young hospitality stars at the finals submitted a video entry to YCYW USA, which was then whittled down by a panel of expert judges, including Roland Passot, propriétaire and chief culinary officer; Adam Busby, certified master chef and general manager of CIA in St. Helena; and more.
These industry veterans also led the in-person judging at the CIA at Copia where finalists were assessed on creativity, innovation, attention to detail and technical ability over an exciting one-day live finale. The USA winners were chosen from a pool of finalists who represented some of the country’s finest establishments, including Knife Pleat, The Surf Club, The French Laundry, Bouchon Bistro, Ad Hoc + Addendum and more.
“We are so proud to host the first-ever YCYW USA competition, as giving these young culinary stars a platform to showcase their skills has always been a priority at SAVOR,” said Shaun Beard, SAVOR’s senior vice president of food and beverage. “During the finale event, not only did we witness remarkable talent from all of the contestants, but we were amazed by their composure, camaraderie, willingness to help and genuine appreciation for each other’s crafts in a high-pressure situation. All competitors have bright and successful futures ahead of them, and we can’t wait to see what they have in store for us next.”
WYCYW aims to highlight the remarkable talent of the finest young professionals building their careers in the industry while championing the skill and passion that hospitality professionals bring to their work. For more information, please visit https://youngchefyoungwaiter.com/.
About SAVOR
SAVOR is the culinary division of ASM Global, the world's leading producer of entertainment experiences, which spans five continents and more than 350 of the world’s most prestigious arenas, stadiums, convention and exhibit centers, and performing arts venues. The team at SAVOR provides top-notch experiences at every event, from the food preparation to the beverage offerings, whether for intimate VIP experiences or banquets with over 20,000 guests. Besides great, authentic chef-driven food, the core elements of SAVOR's food vision include partnerships with local growers, producers and community members; a commitment to using antibiotic-free meats and poultry; and dedication to minimizing impact on the environment through robust sustainability, recycling and composting programs. For more information, please visit savorasmglobal.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230823913776/en/
Contact information
Carla Schalman
breakwhitelight (for ASM Global)
carla@breakwhitelight.com
310-827-3169
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
vVARDIS Announces Investment from Apollo —Achieves Unicorn Status27.4.2026 15:51:00 EEST | Press release
vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulations clinically proven to treat tooth decay. Curodont™ supports enamel repair by facilitating the formation of crystalline mineral structure throughout the affected area, giving dental professionals an easy-to-use, restorative opti
IAS Launches IAS Total TV Solutions Giving Marketers ‘Linear-like’ Transparency for Connected TV27.4.2026 15:30:00 EEST | Press release
Integral Ad Science (IAS) today announced ‘IAS Total TV’, a new comprehensive suite of Connected TV (CTV) solutions designed specifically to bring ‘linear-like’ transparency to streaming TV. IAS Total TV can provide marketers with genre, rating, language, show and program-level data in aggregate from Disney, NBCUniversal, Paramount and Prime Video, in addition to multiple opted-in publishers using Publica. IAS Total TV integrates content insights, media quality, supply path and outcomes into a unified view within the IAS Signal user interface (UI). Advertisers can determine when and how they want their advertising to run alongside CTV content, ensuring brand-related and brand suitable environments. “As advertisers continue to double down on connected TV, the need for greater visibility and performance insight has never been more important,” said Dana McGraw, SVP, Data and Measurement Science, Disney Advertising. “By collaborating with IAS, we’re helping provide advertisers with clearer
Riskified Study Finds Consumers Aren’t Ready to Hand Over Control as AI Transforms Shopping, with Over Half Afraid of Online Fraud27.4.2026 15:00:00 EEST | Press release
Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today released the Q1 2026 edition of its Agentic Commerce Pulse, a quarterly research series tracking agentic commerce risks and consumer engagement. Following Riskified’s inaugural Q4 2025 survey, which first highlighted the rapid emergence of agent-driven commerce, the latest findings reveal a more complex reality: while AI adoption remains strong, consumer trust is not keeping pace. A widening gap is emerging between how shoppers use AI and how much control they are willing to give it. The survey, conducted among consumers across the United States and the United Kingdom, shows that AI is now firmly embedded in product discovery and decision-making. However, compared to Riskified’s agentic commerce pulse survey in Q4 2025, consumer sentiment has shifted, with growing concerns around fraud, security, and accountability slowing the path to fully autonomous, agent-driven transactions. Key findings from th
Nine in 10 Expect Cross-Border M&A Surge, But 71% of Dealmakers Have Already Changed Course on Deals27.4.2026 15:00:00 EEST | Press release
Cross-border M&A is set for a strong resurgence, with nine in 10 senior dealmakers expecting activity to increase over the next 12 to 24 months, according to new research from CSC, the leading provider of business administration and compliance solutions. However, despite this renewed momentum, execution risk is rising, with regulatory scrutiny and operational challenges making it harder to get deals over the line. CSC¹ surveyed 200 director level and above global dealmakers across private equity, corporate, legal, and advisory roles who have worked on cross-border transactions in the past two years. The report, The New Reality of Cross-Border M&A: More Deals, More Friction, explores how firms are navigating an increasingly complex global deal environment. The findings highlight a growing disconnect between ambition and execution. Cross-border transactions are expected to form a significant portion of deal pipelines, with 47% of respondents expecting them to account for between 26% and
Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼ REZZAYO ® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients27.4.2026 14:43:00 EEST | Press release
Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). The ReSPECT Phase III trial, one of the largest antifungal, multicentre, randomised, double-blind studies evaluated the efficacy and safety of once weekly rezafungin compared with a SAR for the prophylaxis of IFDs, including infections caused by Candida, Aspergillus, and Pneumocystis, in adults undergoing allogeneic HSCT. Patients undergoing allogeneic HSCT face prolonged periods of immunosuppression and routinely require extended antifungal prophylaxis,1 representing a setting where differentiated dosing, improved side effect profile, and reduced DDI is beneficial, and comparable efficacy is expected. The ReSPECT study met its primary endpoint for US Food and Drug Administration (FDA) and European Medicines
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom